Breast cancer patients often receive cardiotoxic cancer therapy, and have an increased risk of cardiovascular mortality compared to the general population. In this study, investigators developed a cardiotoxicity risk prediction model using one of the largest cohorts of 26,000 early breast cancer patients.
Learn more here.
Panelists
Presenter
